These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10202047)

  • 21. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.
    Diaz LA; Ratrie H; Saunders WS; Futamura S; Squiquera HL; Anhalt GJ; Giudice GJ
    J Clin Invest; 1990 Oct; 86(4):1088-94. PubMed ID: 1698819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemphigoid gestationis with predominant involvement of oral mucous membranes and IgA autoantibodies targeting the C-terminus of BP180.
    Shimanovich I; Skrobek C; Rose C; Nie Z; Hashimoto T; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 2002 Nov; 47(5):780-4. PubMed ID: 12399776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
    Fairley JA; Fu CL; Giudice GJ
    J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
    Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
    J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnant women have increased incidence of IgE autoantibodies reactive with the skin and placental antigen BP180 (type XVII collagen).
    Noe MH; Messingham KA; Brandt DS; Andrews JI; Fairley JA
    J Reprod Immunol; 2010 Jun; 85(2):198-204. PubMed ID: 20471095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180.
    Lee JB; Liu Y; Hashimoto T
    J Dermatol Sci; 2003 Jun; 32(1):59-64. PubMed ID: 12788530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis.
    Hacker-Foegen MK; Zillikens D; Giudice GJ; Lin MS
    Clin Immunol; 2004 Nov; 113(2):179-86. PubMed ID: 15451475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
    Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
    Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230.
    Thoma-Uszynski S; Uter W; Schwietzke S; Schuler G; Borradori L; Hertl M
    J Immunol; 2006 Feb; 176(3):2015-23. PubMed ID: 16424234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
    Amber KT; Zikry J; Hertl M
    HLA; 2017 Mar; 89(3):127-134. PubMed ID: 28101965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects on the pathogenesis of bullous pemphigoid].
    Schmidt E; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigoid gestationis: maternal sera recognize epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain.
    Sitaru C; Powell J; Shimanovich I; Jainta S; Kirtschig G; Wojnarowska F; Zillikens D
    Br J Dermatol; 2003 Aug; 149(2):420-2. PubMed ID: 12932258
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid.
    Liu Z; Diaz LA; Swartz SJ; Troy JL; Fairley JA; Giudice GJ
    J Immunol; 1995 Dec; 155(11):5449-54. PubMed ID: 7594563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.